Skip to main content
. 2006 Jul;74(7):3904–3911. doi: 10.1128/IAI.02073-05

TABLE 3.

Clinical and parasitological details of subjects

Parameter Value for indicated groupa
Significant relationship(s) between groups (P)b
AM (n = 12) UM (n = 52) SM (n = 42)
Mean age (mo) 46 (38, 54) 30 (26, 34) 28 (24, 32) AM > UM/SM (<0.001)*
Sex (no. of males/no. of females) 6/6 22/30 18/24
Mean parasitemia (parasites/200 leukocytes) 336 (144, 527) 867 (1,067, 2,206) 2,105 (1,883, 3,230) AM < UM < SM (<0.001)*
Mean PCV (%) 29.28 (25.60, 32.95) 27.98 (26.32, 29.64) 25.37 (23.34, 27.4) AM > UM/SM (<0.001)*
Mean lactate (mmol/liter) 3.82 (2.79, 4.84) 2.67 (2.4, 2.9) 2.9 (2.6, 2.3) AM > UM (0.02)*
Mean glucose level (mmol/liter) (95% CI) 4.97 (4.22, 5.71) 5.1 (4.62, 5.58) 5.24 (4.68, 5.81) 0.491*
No. of days of illness Not applicable 2.6 (2.3, 2.9) 2.8 (2.5, 3.1) 0.526**
Mean MUAC (cm) Not determined 15.96 (15.02, 15.71) 15.36 (15.56, 16.36) 0.01**
No. of patients with prostration/total no. of patients 0/12 40/42
No. of patients with impaired consciousness, coma, or neurological alterations (Blantyre score of ≤3)/total no. of patients 0/12 0/52 7/42
a

Values in parentheses are 95% confidence intervals.

b

*, analysis of variance/Kruskal-Wallis test; **, t test.